Bart Welten
Plus aucun poste en cours
Profil
Bart Welten served as Chief Financial Officer at Avantium NV from 2020 to 2023, at DSM Resins BV from 2006 to 2012, and at Centrient Pharmaceuticals Netherlands BV in 2018-2019.
He also held the position of Chief Financial Officer at DSM Anti Infectives BV.
Mr. Welten holds an MBA from Boston College and an undergraduate degree from the University of Leiden.
Anciens postes connus de Bart Welten
| Sociétés | Poste | Fin |
|---|---|---|
| AVANTIUM N.V. | Director of Finance/CFO | 01/01/2023 |
Centrient Pharmaceuticals Netherlands BV
 Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands. | Director of Finance/CFO | 01/02/2019 |
| DSM Resins BV | Director of Finance/CFO | 01/07/2012 |
DSM Anti Infectives BV
 DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Part of DSM BV, DSM Anti Infectives BV is a Dutch company that manufactures ingredients for antibiotics. The private company is based in Delft, the Netherlands. DSM Anti Infectives was acquired by Sinochem Group Co., Ltd. from DSM BV on August 31, 2011 for $277.08 million. | Director of Finance/CFO | - |
Formation de Bart Welten
| Boston College | Masters Business Admin |
| University of Leiden | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AVANTIUM N.V. | Producer Manufacturing |
| Entreprise privées | 3 |
|---|---|
| DSM Resins BV | |
Centrient Pharmaceuticals Netherlands BV
Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands. | Health Technology |
DSM Anti Infectives BV
DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Part of DSM BV, DSM Anti Infectives BV is a Dutch company that manufactures ingredients for antibiotics. The private company is based in Delft, the Netherlands. DSM Anti Infectives was acquired by Sinochem Group Co., Ltd. from DSM BV on August 31, 2011 for $277.08 million. | Health Technology |
